Crossmark

Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab

Crossref DOI link: https://doi.org/10.1186/s12886-018-0701-x

Published Online: 2018-02-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brogan, Kerr http://orcid.org/0000-0002-8204-0887
Precup, Monica

Rodger, Amanda

Young, David

Gilmour, David Francis
More Information

Article History

Received: 1 July 2017

Accepted: 31 January 2018

First Online: 9 February 2018

Ethics approval and consent to participate

: Adhering to the West of Scotland Research Ethics Service review, ethics approval was not required for this study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.